The world of mutual funds offers a plethora of options, each catering to distinct investor goals and risk tolerances. Two such options that often cause confusion for those who invest in mutual funds are contra funds and value funds. While both may hold undervalued stocks, their investment philosophies and target characteristics differ. This blog delves into the core distinctions between contra and value funds, empowering you to make informed investment decisions.
Contra funds, also known as counterpoint funds, take an unconventional approach. They actively seek out stocks that are currently out of favour with the market and are experiencing negative price momentum. The fund manager believes these stocks possess hidden potential and are temporarily undervalued due to market sentiment or short-term setbacks.
Value funds, on the other hand, focus on identifying stocks with a strong underlying value proposition that may be trading at a price below their intrinsic worth. This intrinsic value is determined through fundamental analysis, considering factors like a company's financial health, assets, earnings potential, and competitive advantage.
The ideal choice between contra and value funds depends on your individual risk tolerance and investment goals:
Related article: Growth funds vs value funds
Contra and value funds offer distinct investment approaches. Understanding their core differences – focus on underperforming vs. undervalued stocks, risk-reward profiles, and suitability for different market conditions – is crucial. By aligning your investment goals and risk tolerance with the characteristics of each fund type, you can make informed decisions and choose the option that best complements your overall portfolio strategy. Remember, diversification is key! Consider incorporating both contra and value funds alongside other asset classes to achieve a well-rounded investment portfolio.

T+1 And T+2 Settlement Explained: Meaning, Impact And Holiday Rules
3 min Read May 29, 2026
Stocks to buy for long term: HDFC Bank, HCC among 8 stocks Ventura's Vinit Bolinjkar suggests for 18-115% gains
3 min Read May 29, 2026
Why asset allocation matters more than stock picking in 2026
3 min Read May 29, 2026
Are defence funds overvalued after a 25% rally? What investors must know
3 min Read May 27, 2026
Is this the right time to enter the stock market? Or should you wait?
3 min Read May 26, 2026